ALK2 and JAK2 Inhibition for Improved Treatment of Anemia in Myelofibrosis Patients: Preclinical Profile of an ALK2 Inhibitor Zilurgisertib in Combination with Ruxolitinib

被引：1
|
作者：
Stubbs, Matthew C. [1 ]
Pusey, Michelle [1 ]
Wen, Xiaoming [1 ]
Drake, Katherine [1 ]
Zolotarjova, Nina [1 ]
Smith, Amanda [1 ]
Covington, Maryanne [1 ]
Zhang, Guofeng [1 ]
Macarron, Ricardo [2 ]
Kim, Sunkyu [1 ]
机构：
[1] Incyte Res Inst, Wilmington, DE USA
[2] Incyte, Wilmington, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181055
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinical trial simulation to inform dose selection of zilurgisertib, an ALK2 inhibitor, in patients with anemia due to myelofibrosis (MF)
    Yang, Yan-ou
    Yang, Hong
    Lamothe, Betty
    Stubbs, Matthew
    McBride, Amanda
    Seguy, Francis
    Rockich, Kevin
    Getsy, Jay
    Wang, Phillip
    Liu, Xiang
    Jackson, Jeff
    Asatiani, Ekaterine
    Chen, Xuejun
    CANCER RESEARCH, 2023, 83 (08)
  • [2] Inhibition of ALK2 with bicyclic pyridyllactams
    Witten, Michael R.
    Wu, Liangxing
    Lai, Cheng-Tsung
    Kapilashrami, Kanishk
    Pusey, Michelle
    Gallagher, Karen
    Chen, Yaoyu
    Yao, Wenqing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 55
  • [3] Phase I/II Study of the Activin Receptor-Like Kinase 2 (ALK2) Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia Due to Myelofibrosis
    Bose, Prithviraj
    Mohan, Sanjay
    Oh, Stephen
    Gotlib, Jason
    Ritchie, Ellen
    Shimomura, Taizo
    Ali, Haris
    Boyer, Francoise
    Guglielmelli, Paola
    Hunter, Anthony
    Lamothe, Betty
    Cui, Yi
    Seguy, Francis
    McBride, Amanda
    Palandri, Francesca
    Takeuchi, Masahiro
    Kiladjian, Jean-Jacques
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S401 - S402
  • [4] Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia
    Chen, Yaoyu
    Stubbs, Matthew C.
    Pusey, Michelle
    Wen, Xiaoming
    Collins, Robert J.
    Kapilashrami, Kanishk
    Rupar, Mark
    Thekkat, Pramod
    Lin, Luping
    Bowman, Kevin
    Yang, Yan-ou
    Diamond, Sharon
    Yeleswaram, Swamy
    Kim, Sunkyu
    Koblish, Holly K.
    Chen, Yingnan
    Wee, Susan
    BLOOD, 2020, 136
  • [5] The Jak1/Jak2 Inhibitor Momelotinib Inhibits Alk2, Decreases Hepcidin Production and Ameliorates Anemia of Chronic Disease (ACD) in Rodents
    Asshoff, Malte
    Warr, Matthew
    Haschka, David
    Tymoszuk, Piotr
    Petzer, Verena
    Demetz, Egon
    Maciejewski, Pat
    Seifert, Markus
    Nairz, Manfred
    Posch, Wilfried
    Fowles, Peter
    Weiss, Guenter
    Whitney, Andy
    Theurl, Igor
    BLOOD, 2015, 126 (23)
  • [6] In vivo activity of SGI-1252, a potent, small-molecule dual inhibitor of JAK2 and ALK2
    David, Vollmer
    Bearss, Jared
    Jones, Carissa
    McCarthy, Virgil
    Gourley, Eric
    Liu, Xiao-Hui
    Vankayalapati, Hariprasad
    Warner, Steven
    Olsen, Colin
    Bearss, David
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] TP-0184 IS AN INHIBITOR OF ALK2 AND A POTENTIAL THERAPEUTIC FOR THE TREATMENT OF ANEMIA OF CHRONIC DISEASE
    Peterson, Peter
    Kim, Wontak
    Haws, Hillary
    Whatcott, Clifford
    Siddiqui-Jain, Adam
    Bearss, David
    Warner, Steven
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E355 - E355
  • [8] JAK2 inhibitor treatment of anemia in myelofibrosis
    Tefferi, Ayalew
    Vannucchi, Alessandro M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (07) : 995 - 997
  • [9] Nanocyclix® ALK2 Inhibitors to overcome cancer-induced anemia
    Benderitter, Pascal
    Caradec, Josselin
    Nicodeme, Edwige
    Bouillot, Anne
    Vaulont, Sophie
    Viollet, Benoit
    CANCER RESEARCH, 2020, 80 (16)
  • [10] A Monoclonal Antibody Targeting ALK2 As a Potential Therapeutic Agent for Anemia of Inflammation
    Medeiros, Natalia
    Backus, Thomas A.
    Mater, Christopher
    Fisher, Ffolliott
    Lachey, Jenn
    Seehra, Jasbir
    BLOOD, 2021, 138
12345